ClinicalTrials.Veeva

Menu

Safe Discharge in Lower Gastrointestinal Bleeding

G

Germans Trias i Pujol Hospital

Status

Completed

Conditions

Lower GI Bleeding

Treatments

Other: Safe discharge

Study type

Observational

Funder types

Other

Identifiers

NCT06409988
EO ALTA SEGURA

Details and patient eligibility

About

The increasing incidence in lower gastrointestinal bleeding (LGIB) leads to a rise in hospital admission. Many LGBI are self-limiting thus the several scores to identify low risk patients suited to outpatient care have been described. We aim to compare two of this scores (Oakland score and SHA2PE score) in terms of performace to predict "safe discharge" from the emergency department.

Full description

The growing incidence of lower gastrointestinal bleeding (LGIB) is leading to a rise in hospital admissions even though most LGIB episodes are self-limiting. The Oakland and SHA2PE scores were designed to identify patients best suited to outpatient care. Our aim is to validate the SHA2PE score and compare both of these scores in terms of predictiveness of safe discharge.

We conducted a retrospective observational study of LGIB patients admitted to our hospital between June 2014-June 2019. During this period, data from all LGIB episodes admitted from the ED were collected in an electronic anonymized database created specifically for this study. If any of the principal variables or critical information was missing, the patient was excluded from the study.

Enrollment

398 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All > 18 year old patients, male and women, admitted to our hospital between June 2014 and June 2019 because of LGIB (lower gastrointestinal bleeding).

Exclusion criteria

  • Patients in whom LGIB occurred while already admitted for an other cause.
  • Patients with LGIB transferred from another hospital due to comorbidities or severity of the gastrointestinal bleeding episode.
  • Patients with post-polypectomy LGIB (endoscopic polypectomy <14 days before admission).
  • Patients with gastrointestinal bleeding of unknown origin after a complete study.
  • Patients who had undergone digestive tract surgery in the previous month.
  • Patients with an ostomy.
  • Patients with known colorectal cancer who had not undergone surgery.

Trial design

398 participants in 1 patient group

Patients with lower gastrointestinal bleeding
Description:
Any \>18 years old patient admitted to our hospital due to a lower gastrointestinal bleeding episode.
Treatment:
Other: Safe discharge

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems